Q4 numbers, views from JP Morgan and an open discussion of what the Trump Administration's Impact may be on Healthcare-Harry Wachob and Attendees-01/24/2017 - 8:30am

Event Information
Event Topic: 
Q4 numbers, views from JP Morgan and an open discussion of what the Trump Administration's Impact may be on Healthcare
Event Date: 
01/24/2017 - 8:30am
Event Location: 
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale
Speaker Information
Event Speaker: 
Harry Wachob and Attendees
Event Speaker Company: 
B2DG
Event Speaker Bio: 

Harry Wachob is the Founder and President of the Bio2Device Group. He is an experienced engineering leader in materials science, biomedical device engineering and R&D. He has directed and mentored multidisciplinary teams in solving complex technical issues in order to improve the safety, reliability, and performance of medical devices. Most recently, he was the Managing Materials Scientist at Xoft. Previously he was Director of Engineering for Aerogen, a biopharmaceutical company specializing in novel aerosol drug delivery. Prior to that, Harry was Managing Engineer at Exponent/Failure Analysis Associates where he guided research and development, and product failure investigations covering a broad range of medical and industrial applications. He received his engineering degrees in Materials Science & Engineering from Cornell University.

Event Details
Cost: 
$0
Event Details: 

NO invited speaker. A brief discussion of the preliminary 16Q4 VC numbers, a review of opinions and thoughts about the JP Morgan Life Science Conference, and an open discussion of what the Trump Administration's impact will be on Healthcare and the life sciences in Silicon Valley.